← back to search

Lisa Rice

Moderna Therapeutics (United States) · US
Area of research
Pathology and Forensic Medicine · Clinical Biochemistry
Research interest
Research interests include Systemic Sclerosis and Related Diseases, Metabolism and Genetic Disorders, Connective Tissue Growth Factor Research, and Pulmonary Hypertension Research and Treatments.
h-index
17
citations
1,378
works
46
NIH funding
primary concept
email

Recent publications

mRNA therapy corrects defective glutathione metabolism and restores ureagenesis in preclinical argininosuccinic aciduria
Science Translational Medicine 2024cited by 33position: middledoi
Biomarkers of haemodynamic severity of systemic sclerosis-associated pulmonary arterial hypertension by serum proteome analysis
Annals of the Rheumatic Diseases 2022cited by 39position: middledoi
mRNA therapy restores euglycemia and prevents liver tumors in murine model of glycogen storage disease
Nature Communications 2021cited by 67position: middledoi
Systemic modified messenger RNA for replacement therapy in alpha 1-antitrypsin deficiency
Scientific Reports 2020cited by 51position: middledoi
Single Cell RNA Sequencing Identifies HSPG2 and APLNR as Markers of Endothelial Cell Injury in Systemic Sclerosis Skin
Frontiers in Immunology 2018cited by 88position: middledoi
Skin Gene Expression Is Prognostic for the Trajectory of Skin Disease in Patients With Diffuse Cutaneous Systemic Sclerosis
Arthritis & Rheumatology 2018cited by 63position: middledoi
Altered Dermal Fibroblasts in Systemic Sclerosis Display Podoplanin and CD90
American Journal Of Pathology 2016cited by 58position: middledoi
A Proteome-Derived Longitudinal Pharmacodynamic Biomarker for Diffuse Systemic Sclerosis Skin
Journal of Investigative Dermatology 2016cited by 35position: firstdoi
Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients
Journal of Clinical Investigation 2015cited by 342position: firstdoi
A Longitudinal Biomarker for the Extent of Skin Disease in Patients With Diffuse Cutaneous Systemic Sclerosis
Arthritis & Rheumatology 2015cited by 111position: firstdoi
Promotion of Inflammatory Arthritis by Interferon Regulatory Factor 5 in a Mouse Model
Arthritis & Rheumatology 2015cited by 52position: middledoi
Chronic Toll-like receptor 4 stimulation in skin induces inflammation, macrophage activation, transforming growth factor beta signature gene expression, and fibrosis
Arthritis Research & Therapy 2014cited by 82position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Robert Lafyatis · La Roche College9 papers (2014–2022)Giuseppina Stifano · Bristol-Myers Squibb (United States)6 papers (2014–2018)Robert W. Simms · Boston University3 papers (2015–2016)Jessica Ziemek · University of Washington3 papers (2015–2016)Allison L. Mathes · Boston University3 papers (2014–2015)Romy Christmann · AbbVie (United States)3 papers (2014–2015)Jessica Gordon · Hospital for Special Surgery3 papers (2015–2016)Michael L. Whitfield · Dartmouth College2 papers (2015–2015)Jung Eun Lee · Samsung Medical Center2 papers (2014–2016)Robert Spiera · Hospital for Special Surgery2 papers (2015–2015)Sarah McLaughlin · Nemours Children’s Clinic2 papers (2015–2015)Julio Mantero · Broad Institute2 papers (2016–2022)Banafsheh Nazari · University of Pittsburgh2 papers (2014–2016)Sashidhar Nakerakanti · Boston University2 papers (2014–2015)Cristina M. Padilla · University of Arizona2 papers (2015–2015)Jeffrey L. Browning · Boston University2 papers (2015–2016) · 1 papers (2022–2022) · 1 papers (2022–2022)Sokratis A. Apostolidis · Translational Therapeutics (United States)1 papers (2018–2018)Xuling Zhu · Guizhou University1 papers (2020–2020)